Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas
Abstract CIC::DUX4 translocation-positive sarcomas (CDS) are rare, highly proliferative tumors associated with chemotherapy resistance. Without a clear understanding of the molecular pathways driving CDS, no effective treatment regimens have been developed. Here, we identify protection against DNA d...
Saved in:
| Main Authors: | Nathan D. Seligson, Anjali Paragji, Feha Shahalam, Binyam Yilma, James L. Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00985-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition
by: Femke C. A. S. Ringnalda, et al.
Published: (2025-08-01) -
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target
by: Willemijn Breunis, et al.
Published: (2025-08-01) -
Does the knowledge of the human immunodeficiency virus serostatus influence the clinical diagnostic proficiency of Kaposi's sarcoma?
by: L.J. van Bogaert
Published: (2013-10-01) -
Complete response of somatic POLE-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapy
by: Natasha E. Charewycz, et al.
Published: (2025-08-01) -
Leveraging homologous recombination repair deficiency in sarcoma
by: Dea Slade, et al.
Published: (2023-03-01)